Clinical Trial Update: Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor stem cell transplantation after a busulfan/fludarabine/methylprednisolone/antithymocyte globulin conditioning regimen in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Neoplasm
• Leukemia
• Myelodysplastic Syndromes
• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)
• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Asan Medical Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED